Neuren Pharmaceuticals Expands Market Presence
Company Announcements

Neuren Pharmaceuticals Expands Market Presence

Neuren Pharmaceuticals Limited (AU:NEU) has released an update.

Neuren Pharmaceuticals Limited has announced the application for quotation of 120,000 new fully paid ordinary securities under the ASX code ‘NEU’, dated Monday, June 17, 2024. This move signifies the company’s latest financial development aimed at potential investors and market watchers.

For further insights into AU:NEU stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskNeuren Pharmaceuticals Sees Surge in H1 Revenue
TipRanks Australian Auto-Generated NewsdeskNeuren Pharmaceuticals Posts Sharp Profit Decline
TipRanks Australian Auto-Generated NewsdeskNeuren Aims to Transform Neurodevelopmental Care
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!